MarketInOut Stock Screener Log In | Sign Up
 

Onconetix Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Onconetix Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.13 mln
Float4.37 mln
Earnings Date11/13/2026

EPS

310
Exceptional

P / E

0.00
Anomalous

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.16
Caution advised

Relative Strength

4 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

Business Description

Onconetix Inc. is a biotechnology company founded in 2018 and based in Cincinnati, Ohio, that develops and sells medical tools focused on men's health and cancer detection across the United States and Europe. Its main product, Proclarix, is a blood-based test used to help detect prostate cancer, offered through a partnership with LabCorp. The company also works with Immunovia AB to bring a pancreatic cancer screening test called PancreaSure to market.

Key Fundamentals

EPS310
P/E0.00
ROE-101
RPS1.09
ROIC-35.24
ROA-53.67
Interest Cover-26.28
EBITDA, mln-9.87
EV / EBITDA0.41
EV / EBIT0.41
Revenue, mln0.65

Quote Details

Last 0.418
Change 0.0112 (2.75%)
Open 0.427
Volume 562,221
Turnover 235,008
Average Volume 6,187,002

Financial Ratios

Pre-Tax Profit Margin-1,579
Leverage Ratio1.22
Current Ratio2.21
Price / Book0.22
Price / Tangible Book0.76
Debt / Equity0.01
Price / Sales0.04

Financial Strength

Altman Z-Score-12.74
Piotroski F-Score 4 / 9
Beneish M-Score-2.16
Short Ratio0.09
Short % of Float9.34

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.7% 12 / 100   
1 Month -54.11% 2 / 100   
2 Months -58.2% 5 / 100   
6 Months -92.89% 1 / 100   
1 Year -99.76% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog